Free Trial
CVE:MFS

Medifocus Inc. (MFS.V) (MFS) Stock Price, News & Analysis

Medifocus Inc. (MFS.V) logo
C$0.01 0.00 (0.00%)
(As of 09/4/2020)

About Medifocus Inc. (MFS.V) Stock (CVE:MFS)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.02
Volume
26,000 shs
Average Volume
317,764 shs
Market Capitalization
C$1.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.

Receive MFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifocus Inc. (MFS.V) and its competitors with MarketBeat's FREE daily newsletter.

MFS Stock News Headlines

MFS Growth R6 MFEKX
MFS Research A MFRFX
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
MFS Research I MRFIX
MFS Intl Diversification A
InsuraGuest Technologies Inc. (ISGI.V)
Vior Inc. (VIO.V)
Beacn Wizardry and Magic Inc. (BECN.V)
See More Headlines

MFS Stock Analysis - Frequently Asked Questions

Medifocus Inc. (MFS.V)'s stock was trading at C$0.01 on January 1st, 2024. Since then, MFS stock has increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2024 here
.

Shares of MFS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifocus Inc. (MFS.V) investors own include (RLYP) (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE) and Chevron (CVX).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Machinery
CIK
N/A
Fax
N/A
Employees
4,800
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.23 million
Cash Flow
C$0.00 per share
Book Value
C($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.85 million
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (CVE:MFS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners